Key result
CD4+ and CD8+ T cells regulate cardiac fibroblast activation and extracellular matrix remodeling post-MI.
Why the study?
Lymphocytes play important roles in post-myocardial infarction cardiac fibrosis, but the specific regulatory effects of lymphocyte subsets on fibroblasts and cardiac remodeling warrant focused synthesis.
This review highlights the complex, biphasic roles of T and B lymphocytes in modulating cardiac fibroblast function and scar formation after myocardial infarction, suggesting potential targets for immunomodulatory therapies in ischemic heart failure.
May guide immunomodulatory targets in post-MI remodeling; leaves open whether T-cell modulation improves ischemic HF outcomes.
Cardiac fibrosis is a pathological condition characterized by excessive accumulation of extracellular matrix components within the myocardium, which can lead to impaired cardiac function and heart failure. Studies have shown that lymphocytes including B and T cells play important roles in the development and progression of cardiac fibrosis after a myocardial infarction. In this review, we focus on the regulation of cardiac fibrosis by lymphocyte subsets, with a particular emphasis on CD4 + and CD8 + T cells and their effects on fibroblasts and cardiac remodeling. We also highlight areas for further exploration of the interactions between T cells and fibroblasts necessary for understanding and treating cardiac fibrosis and heart failure.
No takes yet. Share an insight, caveat, or question.
Learmonth et al. (2023) conducted a review in Myocardial Infarction and Cardiac Fibrosis. Lymphocytes, particularly CD4+ and CD8+ T cells, play critical roles in regulating cardiac fibroblast activation and extracellular matrix remodeling after myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: